Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2011

Conditions
Hand, Foot, and Mouth Disease
Interventions
DRUG

Western therapy (mannitol, methylprednisolone, immunoglobulin, febrifuge)

Mannitol:0.5-1.0g/kg,q4h to q8h ivgtt; Methylprednisolone:1mg-2mg/kg·d,qd iv; Immunoglobulin:1g/kg; Others:febrifuge,sedative,etc.

DRUG

Xiyanping injection plus western therapy

Xiyanping injection:5-10mg/kg/d (0.2-0.4ml/kg/d),qd ivgtt; Mannitol:0.5-1.0g/kg,q4h to q8h ivgtt; Methylprednisolone:1mg-2mg/kg·d,qd iv; Immunoglobulin:1g/kg; Others:febrifuge,sedative,etc.

Trial Locations (3)

Unknown

Liuzhou People's Hospital, Liuzhou

Handan Maternal and Child Health Care Hospital, Handan

Jiangxi Children's Hospital, Nanchang

All Listed Sponsors
collaborator

China Academy of Chinese Medical Sciences

OTHER

collaborator

Beijing YouAn Hospital

OTHER

collaborator

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

OTHER

collaborator

Beijing University of Chinese Medicine

OTHER

lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY